Alvin S. Parven is Director at ALEXION PHARMACEUTICALS INC (ALXN). They have made 24 open-market trades across 1 company since 2008, most recently 2017-06-15.
CIK 0000899866
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $12K since 2012, against 23 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ALXN | 7,568 | $1.4M |
Shares reported on the most recent Form 4, priced at the 2017-06-16 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALXN | SELL | 2017-06-15 | 2017-06-16 | $116.78 | $195K | +9.9% | +9.8% | +26.3% |
| ALXN | SELL | 2017-01-05 | 2017-01-09 | $138.74 | $2.0M | -9.0% | -12.8% | -19.0% |
| ALXN | SELL | 2017-01-05 | 2017-01-09 | $138.35 | $3.1M | -9.0% | -12.8% | -19.0% |
| ALXN | SELL | 2016-08-15 | 2016-08-24 | $136.48 | $2.1M | -4.8% | -3.8% | -11.5% |
| ALXN | SELL | 2015-11-02 | 2015-11-04 | $178.73 | $160K | -15.6% | -1.2% | -26.5% |
| ALXN | SELL | 2014-11-11 | 2014-11-13 | $195.66 | $2.9M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2014-05-13 | 2014-05-15 | $160.78 | $2.0M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2014-02-11 | 2014-02-13 | $174.06 | $430K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2013-03-08 | 2013-03-12 | $92.00 | $287K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2012-11-19 | 2012-11-21 | $91.30 | $2.7M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2012-06-08 | 2012-06-08 | $91.01 | $2.7M | -15.6% | -1.2% | -1.2% |
| ALXN | BUY | 2012-03-05 | 2013-12-11 | $84.95 | $12K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2012-02-21 | 2012-02-23 | $81.51 | $444K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2011-10-31 | 2011-11-01 | $68.00 | $433K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2011-02-17 | 2011-02-22 | $92.45 | $367K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2010-11-09 | 2010-11-12 | $72.32 | $855K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2010-08-31 | 2010-09-02 | $56.72 | $454K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2010-02-18 | 2010-02-18 | $48.68 | $248K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2009-12-11 | 2009-12-14 | $46.12 | $1.4M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2009-07-27 | 2009-07-28 | $40.06 | $601K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2009-03-10 | 2009-03-12 | $32.78 | $131K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2008-08-05 | 2008-08-07 | $91.63 | $870K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2008-06-04 | 2008-06-04 | $70.57 | $445K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2008-02-22 | 2008-02-25 | $61.35 | $123K | -15.6% | -1.2% | -1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.